Diana Hausman, Chief Medical Officer at Zymeworks Inc. (ZYME), sold 12,064 shares at $55.12 ($665K) on 2020-12-04, disclosed to the SEC on 2020-12-04.
Open-market sale of $665k ZYME by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.12 | 6,032 | $332K | 50.0% |
| 2 | $55.12 | 6,032 | $332K | 50.0% |
| Total | $55.12 avg | 12,064 | $665K | 100% |
| Filing → |
| ZYME | SELL | 2021-03-12 | $37K | — | Filing → |
| ZYME | SELL | 2020-12-03 | $2.1M | — | Filing → |
| ZYME | SELL | 2020-09-16 | $1.8M | — | Filing → |